Barclays’s Nature's Sunshine NATR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Sell
29,990
-34,619
-54% -$858K ﹤0.01% 2958
2025
Q4
$1.39M Buy
64,609
+2,310
+4% +$42.4K ﹤0.01% 3198
2025
Q3
$967K Sell
62,299
-742
-1% -$11.9K ﹤0.01% 3385
2025
Q2
$932K Buy
63,041
+26,851
+74% +$363K ﹤0.01% 3388
2025
Q1
$454K Sell
36,190
-1,503
-4% -$21.1K ﹤0.01% 3591
2024
Q4
$553K Buy
37,693
+2,091
+6% +$30.6K ﹤0.01% 3760
2024
Q3
$485K Buy
35,602
+12,152
+52% +$174K ﹤0.01% 3795
2024
Q2
$353K Sell
23,450
-5,724
-20% -$97.7K ﹤0.01% 3253
2024
Q1
$606K Sell
29,174
-8,848
-23% -$160K ﹤0.01% 3469
2023
Q4
$657K Buy
38,022
+16,799
+79% +$290K ﹤0.01% 3709
2023
Q3
$352K Sell
21,223
-583
-3% -$8.85K ﹤0.01% 2997
2023
Q2
$298K Sell
21,806
-7,263
-25% -$82.6K ﹤0.01% 3049
2023
Q1
$297K Buy
29,069
+3,283
+13% +$32.3K ﹤0.01% 3583
2022
Q4
$215K Buy
25,786
+3,033
+13% +$25.7K ﹤0.01% 3798
2022
Q3
$188K Buy
22,753
+1,351
+6% +$13.4K ﹤0.01% 3242
2022
Q2
$228K Sell
21,402
-1,245
-5% -$17.3K ﹤0.01% 3353
2022
Q1
$381K Sell
22,647
-12,468
-36% -$221K ﹤0.01% 3070
2021
Q4
$649K Buy
35,115
+9,548
+37% +$162K ﹤0.01% 3077
2021
Q3
$375K Buy
25,567
+3,346
+15% +$56.2K ﹤0.01% 3325
2021
Q2
$386K Buy
22,221
+14,810
+200% +$293K ﹤0.01% 3220
2021
Q1
$148K Buy
7,411
+4,549
+159% +$78.8K ﹤0.01% 3841
2020
Q4
$43K Sell
2,862
-1,137
-28% -$14.1K ﹤0.01% 4476
2020
Q3
$47K Sell
3,999
-809
-17% -$8.65K ﹤0.01% 4635
2020
Q2
$44K Buy
4,808
+1,864
+63% +$16.2K ﹤0.01% 4986
2020
Q1
$25K Sell
2,944
-5,971
-67% -$54.1K ﹤0.01% 5568
2019
Q4
$80K Buy
8,915
+4,470
+101% +$42K ﹤0.01% 5574
2019
Q3
$37K Sell
4,445
-1,375
-24% -$12.5K ﹤0.01% 6027
2019
Q2
$54K Buy
5,820
+3,210
+123% +$30K ﹤0.01% 6058
2019
Q1
$24K Buy
2,610
+2,363
+957% +$20K ﹤0.01% 6283
2018
Q4
$2K Sell
247
-3,162
-93% -$27.3K ﹤0.01% 6724
2018
Q3
$30K Buy
3,409
+2,786
+447% +$24.6K ﹤0.01% 6314
2018
Q2
$6K Sell
623
-1,614
-72% -$15.1K ﹤0.01% 6678
2018
Q1
$24K Buy
2,237
+534
+31% +$6.15K ﹤0.01% 6352
2017
Q4
$20K Buy
1,703
+1,453
+581% +$16.5K ﹤0.01% 6293
2017
Q3
$3K Buy
250
+243
+3,471% +$2.75K ﹤0.01% 6589
2017
Q2
$0 Sell
7
-32
-82% -$362 ﹤0.01% 6826
2017
Q1
$0 Sell
39
-44
-53% -$512 ﹤0.01% 6898
2016
Q4
$1K Sell
83
-10
-11% -$146 ﹤0.01% 6474
2016
Q3
$1K Buy
93
+45
+94% +$587 ﹤0.01% 6409
2016
Q2
$0 Sell
48
-343
-88% -$3.33K ﹤0.01% 6518
2016
Q1
$4K Buy
+391
New +$3.38K ﹤0.01% 5720
2015
Q4
Sell
-56
Closed -$1K 6365
2015
Q3
$1K Sell
56
-145
-72% -$1.8K ﹤0.01% 6565
2015
Q2
$2K Sell
201
-123
-38% -$1.59K ﹤0.01% 6810
2015
Q1
$4K Sell
324
-559
-63% -$7.64K ﹤0.01% 6690
2014
Q4
$12K Buy
883
+521
+144% +$7.71K ﹤0.01% 6625
2014
Q3
$5K Buy
362
+168
+87% +$2.66K ﹤0.01% 7188
2014
Q2
$3K Sell
194
-234
-55% -$3.35K ﹤0.01% 7283
2014
Q1
$6K Sell
428
-1,222
-74% -$19.3K ﹤0.01% 7139
2013
Q4
$28K Sell
1,650
-144
-8% -$2.65K ﹤0.01% 6530
2013
Q3
$34K Buy
1,794
+1,122
+167% +$20.7K ﹤0.01% 6271
2013
Q2
$11K Buy
+672
New +$10.3K ﹤0.01% 7099

Other funds holding NATR

Barclays's NATR Position: Q1 2026 in Review

Barclays reduced its Nature's Sunshine (NATR) stake by 54% in Q1 2026, selling an estimated $858K and leaving 29,990 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

Barclays first reported a position in NATR in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.39M in Q4 2025. 153 funds tracked by Wall St. Rank hold NATR as of Q1 2026.

  • Barclays held 29,990 shares of Nature's Sunshine worth $719K as of Q1 2026.
  • Barclays sold 34,619 Nature's Sunshine shares in Q1 2026, an estimated $858K.
  • Nature's Sunshine made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2958 holding.
  • Barclays first reported a position in Nature's Sunshine in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Nature's Sunshine position peaked at $1.39M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Nature's Sunshine as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.